HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto's 2000 Momentum Faces 2001 Question: Where Is Clairol Going?

This article was originally published in The Rose Sheet

Executive Summary

Alberto-Culver's renewed growth in North American markets during 2000 on the strength of VO5 Herbals and St. Ives facial and body washes earned the company a strong and sustained increase from Wall Street throughout the year.

You may also be interested in...



Defensive Economy To Benefit Consumer Products Group - Goldman Sachs

Predictions for a slowing economy could benefit the consumer products group in 2001, as investors turn away from risky stock picks toward defensive stocks, Goldman Sachs analyst Amy Low Chasen said.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel